Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows From Operating Activities:
Net loss	$ (17,291,732)	$ (18,471,333)
Adjustments to reconcile net loss to cash used in operating activities
Change in fair value of warrant liability	(94,396)	(4,315,236)
Change in fair value of investment option liability	(208,752)	(3,472,726)
Change in fair value of derivative liability	(727,000)	325,000
Stock-based compensation	2,150,160	2,620,671
Inducement expense	1,848,235
Impairment of intangibles		7,453,662
Non-cash income tax benefit		(1,504,302)
Amortization of ROU asset	64,048	107,291
Amortization of intangibles	168,754	168,750
Depreciation expense	175,228	159,160
Gain on disposal of property and equipment	(4,206)
Change in operating assets and liabilities:
Prepaid expenses and other current assets	(6,857)	(374,058)
Accounts payable and accrued liabilities	(103,848)	263,686
Right-of-use operating lease asset and obligation	(64,045)	(107,288)
Net cash used in operating activities	(14,094,411)	(17,146,723)
Cash Flows From Investing Activities:
Purchases of property and equipment	(5,180)	(584,165)
Proceeds from disposal of property and equipment	16,847
Net cash provided by (used in) investing activities	11,667	(584,165)
Cash Flows From Financing Activities:
Proceeds from sale of common stock, warrants, and investment options, net of offering costs		17,222,099
Payment for equity distribution offering costs	(291,084)
Redemption of Series A Preferred Stock	(1,052,057)
Proceeds from the sale of redeemable non-controlling interest, net of offering costs		958,038
Net cash (used in) provided by financing activities	(1,343,141)	18,180,137
Effect of Foreign Exchange Rate on Changes on Cash	(10,022)	(81,364)
Net (decrease) increase in cash	(15,435,907)	367,885
Cash at beginning of year	17,723,884	17,355,999
Cash at end of year	2,287,977	17,723,884
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest		5,249
Income taxes paid	9,507
Warrants issued in conjunction with common stock issuance		3,595,420
Issuance of embedded derivative		402,000
Stock subscription receivable	1,817,640
Offering costs accrued not paid	182,724
Warrants issued for offering costs	77,991
Issuance of common shares for deferred offering costs	255,107
Induced conversion of warrants and preferred investment options	683,997
Preferred dividends attributable to redeemable non-controlling interest	19,041	33,014
Investment options issued in conjunction with common stock issuance		4,323,734
Modification of warrants as part of share capital raise		251,357
Accretion of embedded derivative to redemption value	$ 147,988	$ 295,976